Dobutamine and hydralazine: Comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 1 (2) , 499-505
- https://doi.org/10.1016/s0735-1097(83)80079-5
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.Circulation, 1982
- Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.Circulation, 1981
- Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.Circulation, 1981
- How much can we expect from vasodilator therapy in congestive heart failure?Circulation, 1979
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.Circulation, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening.Circulation, 1976
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971